Total Raised

$2.22M

Investors Count

4

Funding, Valuation & Revenue

3 Fundings

Klarismo has raised $2.22M over 3 rounds.

Klarismo's latest funding round was a Dead for on January 1, 2017.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/1/2017

Dead

Dead

$XXM

0

FY undefined

8/20/2015

Seed

$XXM

$XXM

0

FY undefined

10

7/24/2015

Seed VC

$XXM

$XXM

0

FY undefined

10

Date

1/1/2017

8/20/2015

7/24/2015

Round

Dead

Seed

Seed VC

Amount

$XXM

$XXM

Investors

Dead

Valuation

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

10

10

Start free trial
New call-to-action

Klarismo Investors

4 Investors

Klarismo has 4 investors. Y Combinator invested in Klarismo's Seed funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/20/2015

8/20/2015

1
Seed

Incubator/Accelerator

California

00/00/0000

00/00/0000

Khosla Ventures

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Lowercase Capital

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Atomico

Subscribe to see more

Venture Capital

United Kingdom

First funding

8/20/2015

00/00/0000

00/00/0000

00/00/0000

Last Funding

8/20/2015

00/00/0000

00/00/0000

00/00/0000

Investor

Khosla Ventures

Lowercase Capital

Atomico

Rounds

1
Seed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Incubator/Accelerator

Venture Capital

Venture Capital

Venture Capital

Location

California

California

California

United Kingdom

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.